wilson-report on bta-website

Im wondering why Biota-management has released the
ignorant and amateurish Wilson-report on BTA-website.

As already mentioned by many users, this report completely ignores the entire Biota-pipeline and it also works with strange figures (Relenza-price only A$20 although imho A$25 should be the correct price).

Why must a report that speculates about low Relenza-sales
be featured on BTA-company website 5 DAYS BEFORE OFFICIAL FIGURES COME OUT ?!

Let me quote what Mr. Lismore (CFO Biota) says about the
analysts-reports that are featured on BTA-website:
"Analyst Reports

The Directors and Biota Management do not endorse any Analyst Report and suggest that investors and potential investors consult their own financial advisor before making all investment decisions. However, WHERE AN ANALYST HAS CONDUCTED SIGNIFICANT RESEARCH, IN OUR VIEW, AND HAS GIVEN PERMISSION, BIOTA WILL MAKE A COPY AVAILABLE ON THE BIOTA WEBSITE.

Damian Lismore
Company Secretary"

Is it a "SIGNIFICANT RESEARCH" TO IGNORE BTAs ENTIRE
PIPELINE INCL. LANI/PHASE 3 ???!!!

Im very upset about stuff like this.

Sometimes BTA-management and their special kind of
"public relations" is very hard to understand...
It seems that these are great guys in terms of Biotech,
but they still have a long way to go in terms of PR.

Regards from Germany
Eric